ENTA – Enanta Pharmaceuticals Inc
ENTA — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
7.86
Margin Of Safety %
Put/Call OI Ratio
0.24
EPS Next Q Diff
-0.07
EPS Last/This Y
1.71
EPS This/Next Y
-0.08
Price
13.42
Target Price
18.71
Analyst Recom
1.43
Performance Q
-3.45
Upside
-934.0%
Beta
1.01
Ticker: ENTA
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | ENTA | 13.88 | 0.20 | 0.40 | 1250 |
| 2026-03-10 | ENTA | 13.92 | 0.20 | 0.40 | 1250 |
| 2026-03-11 | ENTA | 14.15 | 0.20 | 0.40 | 1250 |
| 2026-03-12 | ENTA | 13.42 | 0.20 | 0.40 | 1250 |
| 2026-03-13 | ENTA | 13.41 | 0.20 | 0.40 | 1250 |
| 2026-03-17 | ENTA | 13.31 | 0.23 | 999.99 | 1282 |
| 2026-03-18 | ENTA | 12.68 | 0.24 | 0.83 | 1293 |
| 2026-03-20 | ENTA | 12.55 | 0.15 | 999.99 | 1223 |
| 2026-03-25 | ENTA | 12.18 | 0.22 | 3.67 | 1164 |
| 2026-03-26 | ENTA | 12.55 | 0.23 | 999.99 | 1178 |
| 2026-03-27 | ENTA | 12.19 | 0.23 | 999.99 | 1178 |
| 2026-03-30 | ENTA | 12.16 | 0.23 | 999.99 | 1178 |
| 2026-03-31 | ENTA | 12.61 | 0.23 | 999.99 | 1178 |
| 2026-04-01 | ENTA | 12.93 | 0.23 | 999.99 | 1178 |
| 2026-04-06 | ENTA | 13.23 | 0.25 | 0.04 | 1196 |
| 2026-04-07 | ENTA | 13.42 | 0.24 | 0.00 | 1240 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | ENTA | 13.88 | 52.1 | - | -2.13 |
| 2026-03-10 | ENTA | 13.95 | 52.1 | - | -2.13 |
| 2026-03-11 | ENTA | 14.13 | 52.1 | - | -2.13 |
| 2026-03-12 | ENTA | 13.46 | 52.1 | - | -2.13 |
| 2026-03-13 | ENTA | 12.69 | 52.1 | - | -2.13 |
| 2026-03-17 | ENTA | 13.27 | 52.1 | - | -2.13 |
| 2026-03-18 | ENTA | 12.73 | 52.1 | - | -2.13 |
| 2026-03-19 | ENTA | 13.03 | 52.1 | - | -2.13 |
| 2026-03-20 | ENTA | 12.51 | 52.1 | - | -2.13 |
| 2026-03-23 | ENTA | 12.66 | 52.1 | - | -2.13 |
| 2026-03-24 | ENTA | 12.10 | 52.1 | - | -2.13 |
| 2026-03-25 | ENTA | 12.19 | 52.1 | - | -2.13 |
| 2026-03-26 | ENTA | 12.49 | 52.1 | - | -2.13 |
| 2026-03-27 | ENTA | 12.19 | 52.1 | - | -2.13 |
| 2026-03-30 | ENTA | 12.17 | 52.1 | - | -2.13 |
| 2026-03-31 | ENTA | 12.61 | 52.1 | - | -2.13 |
| 2026-04-01 | ENTA | 12.94 | 52.1 | - | -2.13 |
| 2026-04-02 | ENTA | 13.13 | 52.1 | - | -2.13 |
| 2026-04-06 | ENTA | 13.23 | 52.1 | - | -2.13 |
| 2026-04-07 | ENTA | 13.42 | 52.1 | - | -2.13 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | ENTA | -0.86 | 18.15 | 8.27 |
| 2026-03-10 | ENTA | -0.86 | 18.15 | 8.27 |
| 2026-03-11 | ENTA | -0.86 | 18.15 | 7.94 |
| 2026-03-12 | ENTA | -0.86 | 18.15 | 7.94 |
| 2026-03-13 | ENTA | -0.86 | 18.15 | 7.94 |
| 2026-03-18 | ENTA | -0.86 | 18.10 | 7.94 |
| 2026-03-19 | ENTA | -0.86 | 18.10 | 7.94 |
| 2026-03-20 | ENTA | -0.86 | 18.10 | 7.94 |
| 2026-03-23 | ENTA | -0.86 | 18.11 | 7.94 |
| 2026-03-24 | ENTA | -0.86 | 18.11 | 7.94 |
| 2026-03-25 | ENTA | -0.86 | 18.11 | 7.86 |
| 2026-03-26 | ENTA | -0.86 | 18.11 | 7.86 |
| 2026-03-27 | ENTA | -0.86 | 18.11 | 7.86 |
| 2026-03-30 | ENTA | -0.86 | 18.24 | 7.86 |
| 2026-03-31 | ENTA | -0.86 | 18.24 | 7.86 |
| 2026-04-01 | ENTA | -0.86 | 18.24 | 7.86 |
| 2026-04-02 | ENTA | -0.86 | 18.24 | 7.86 |
| 2026-04-06 | ENTA | -0.86 | 18.24 | 7.86 |
| 2026-04-07 | ENTA | -0.86 | 18.24 | 7.86 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.42
Avg. EPS Est. Current Quarter
-0.51
Avg. EPS Est. Next Quarter
-0.49
Insider Transactions
-0.86
Institutional Transactions
18.24
Beta
1.01
Average Sales Estimate Current Quarter
16
Average Sales Estimate Next Quarter
16
Fair Value
Quality Score
28
Growth Score
26
Sentiment Score
91
Actual DrawDown %
86.8
Max Drawdown 5-Year %
-95.6
Target Price
18.71
P/E
Forward P/E
PEG
P/S
5.82
P/B
3.08
P/Free Cash Flow
EPS
-3.2
Average EPS Est. Cur. Y
-2.13
EPS Next Y. (Est.)
-2.21
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-106.8
Relative Volume
0.48
Return on Equity vs Sector %
-84
Return on Equity vs Industry %
-67.4
EPS 1 7Days Diff
EPS 1 30Days Diff
0.22
EBIT Estimation
◆
ENTA
Healthcare
$13.43
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
54
Range 1M
65.9%
Sup Dist
4.4%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
35.7%
EPS NY
19.4%
52W%
71.4%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+39.3% upside
Upside
+39.3%
Quality
28
Enanta Pharmaceuticals, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 120
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for virology and immunology indications. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; zelicapavir and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; EDP-978 for chronic spontaneous urticaria (CSU); Glecaprevir, antiviral protease inhibitors for the treatment of chronic infection with hepatitis C virus or HCV; and EPS-3903 for the treatment of atopic dermatitis. It has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts.
ENTA
Latest News
—
Caricamento notizie per ENTA…
stock quote shares ENTA – Enanta Pharmaceuticals Inc Stock Price stock today
news today ENTA – Enanta Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ENTA – Enanta Pharmaceuticals Inc yahoo finance google finance
stock history ENTA – Enanta Pharmaceuticals Inc invest stock market
stock prices ENTA premarket after hours
ticker ENTA fair value insiders trading